Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Europe symbols : ABBV save search
Waste Management Market to grow by USD 167.1 billion, laws in Europe for recycling waste to boost market growth, Technavio
Published: 2024-03-22 (Crawled : 18:00) - prnewswire.com
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
| Email alert
Add to watchlist
ABT | News | $105.27 -0.6% -0.15% 7.3M
|
Health Technology
| Email alert
Add to watchlist
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
| Email alert
Add to watchlist
europe management market
Baby Safety Market size to grow by USD 3,578.36 million from 2022 to 2027, Europe to account for 30% of the market growth - Technavio
Published: 2023-05-19 (Crawled : 00:20) - prnewswire.com
CODI | News | $22.33 0.86% 0.0% 190K
|
Finance
| Email alert
Add to watchlist
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
| Email alert
Add to watchlist
NWL | News | $6.9 -0.43% -0.43% 4.7M
|
Producer Manufacturing
| Email alert
Add to watchlist
europe baby growth market
Anti-cellulite Care Products Market size to grow at a CAGR of 4.75% from 2021 to 2026, Europe is estimated to account for 33% of the market growth - Technavio
Published: 2023-04-12 (Crawled : 19:00) - prnewswire.com
UNLYF | $47.0 1.3% 460
|
Consumer Non-Durables
|
| O: -1.71%
H: 0.36%
C: 0.36%
UL | $46.85 0.34% -0.09% 5.7M
|
Consumer Non-Durables
|
| O: 0.62%
H: 0.73%
C: 0.65%
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: -0.84%
H: 1.16%
C: 1.05%
europe care growth market
Biosimilars market size to increase by USD 42,227.12 million: Europe to contribute 46% of market growth - Technavio
Published: 2022-12-08 (Crawled : 00:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: -0.89%
H: 0.0%
C: 0.0%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.55%
H: 0.39%
C: 0.39%
VTRS | $11.11 0.09% 0.09% 3.5M
|
Health Technology
|
| O: 0.0%
H: 0.82%
C: -1.64%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.24%
H: 0.32%
C: -0.93%
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 0.46%
H: 0.59%
C: -2.22%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.15%
H: 0.0%
C: 0.0%
BIIB | $190.55 -0.84% -0.84% 1.5M
|
Health Technology
|
| O: 0.0%
H: 1.34%
C: -1.29%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: -0.48%
H: 0.35%
C: -1.95%
europe growth market
Rheumatoid Arthritis Drugs Market Size to Grow by USD 14.90 Billion | 37% of the growth will originate from Europe | Technavio
Published: 2022-06-24 (Crawled : 09:00) - prnewswire.com
ALPMF | $9.594 43.47% 2.2K
|
Health Technology
|
| O: 0.99%
H: 0.0%
C: -0.5%
GLAXF | $20.2 -14.18% 510
|
Health Technology
|
| O: 3.19%
H: 2.28%
C: -1.81%
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 8.01%
H: 0.0%
C: 0.0%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: 6.71%
H: 0.0%
C: -0.1%
ALPMY | $9.46 -1.11% 500K
|
Manufacturing
|
| O: 4.33%
H: 0.0%
C: -2.44%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 2.38%
H: 0.0%
C: 0.0%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: 1.26%
H: 0.95%
C: 0.92%
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 1.57%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 3.49%
H: 0.0%
C: 0.0%
GLMD | $0.3669 -0.41% -0.41% 27K
|
Health Technology
|
| O: 1.21%
H: 0.0%
C: -3.5%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: 0.37%
H: 0.82%
C: 0.56%
europe growth market drug
Parkinson's Disease (PD) Drugs market - 37% of Growth to Originate from Europe | Evolving Opportunities with AbbVie Inc. & Amneal Pharmaceuticals Inc. | Technavio
Published: 2022-05-18 (Crawled : 07:00) - prnewswire.com
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: -0.31%
H: 0.53%
C: -0.19%
GSK | $39.27 -0.83% 0.01% 2.2M
|
Health Technology
|
| O: -0.43%
H: 0.0%
C: 0.0%
BHC | $8.6 -0.69% 0.0% 2.1M
|
Health Technology
|
| O: -0.72%
H: 1.09%
C: -9.3%
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: -0.17%
H: 0.59%
C: -1.52%
ACAD | $17.08 -0.64% -0.64% 990K
|
Health Technology
|
| O: -3.61%
H: 1.39%
C: -3.14%
europe disease growth market
Ascletis Announces Submission of Marketing Authorization Applications for Ritonavir in Eight Additional European Countries
Published: 2022-03-01 (Crawled : 10:00) - prnewswire.com
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 0.99%
H: 0.0%
C: 0.0%
europe application authorization submission
AbbVie Showcases Its Leadership in Research in Inflammatory Bowel Diseases with New Analyses to be Presented at the 17th Congress of European Crohn's and Colitis Organization (ECCO)
Published: 2022-02-01 (Crawled : 14:00) - prnewswire.com
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 0.13%
H: 0.0%
C: 0.0%
europe research disease
AbbVie Submits Application for Risankizumab (SKYRIZI®) in Moderate to Severe Crohn's Disease to European Medicines Agency (EMA)
Published: 2021-11-30 (Crawled : 13:30) - biospace.com/
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: -0.35%
H: 0.0%
C: 0.0%
ema europe application disease risankizumab
AbbVie Expands Immunology Portfolio in the European Union with the European Commission Approval of SKYRIZI® (risankizumab) for the Treatment of Adults with Active Psoriatic Arthritis
Published: 2021-11-17 (Crawled : 09:00) - prnewswire.com
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: -0.09%
H: 0.87%
C: 0.64%
treatment europe immunology risankizumab approval
AbbVie Receives CHMP Positive Opinion for Risankizumab (SKYRIZI®) for the Treatment of Adults with Active Psoriatic Arthritis in the European Union (EU)
Published: 2021-10-15 (Crawled : 13:15) - biospace.com/
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 0.22%
H: 0.74%
C: 0.16%
treatment europe positive risankizumab chmp
AbbVie Presents Late-Breaking Data on Risankizumab (SKYRIZI®) in Psoriatic Arthritis at the 30th European Academy of Dermatology and Venereology (EADV) Congress
Published: 2021-09-30 (Crawled : 19:00) - biospace.com/
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 0.33%
H: 1.12%
C: -1.22%
europe risankizumab
AbbVie Presents New Data Analyses for Growing Dermatology Portfolio at the 30th European Academy of Dermatology and Venereology (EADV) Congress
Published: 2021-09-23 (Crawled : 13:00) - biospace.com/
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 0.55%
H: 1.2%
C: 0.35%
europe growing
Alvotech Announces Positive Top-Line Results for Switching Study Between Proposed Biosimilar AVT02 and Humira®
Published: 2021-09-09 (Crawled : 22:00) - biospace.com/
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: -0.83%
H: 0.27%
C: -1.98%
positive results topline biosimilar
European Commission Approves RINVOQ® (upadacitinib) as First JAK Inhibitor in the European Union for the Treatment of Both Adults and Adolescents with Moderate to Severe Atopic Dermatitis
Published: 2021-08-24 (Crawled : 14:00) - biospace.com/
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: -0.03%
treatment europe dermatitis atopic dermatitis
Office Stationery Market to grow by $ 8.06 Billion in Europe during 2021-2025 | Technavio
Published: 2021-07-08 (Crawled : 03:00) - prnewswire.com
AMCR | News | $8.9 0.79% 0.0% 5.8M
|
Process Industries
|
| O: -0.87%
H: 0.48%
C: -0.52%
ABBV | News | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: -0.85%
H: 0.91%
C: 0.51%
europe
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.